• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Life Science Market
    Life Science News
    Life Science Stocks
    • Life Science Market
    • Life Science News
    • Life Science Stocks

    Revive Therapeutics: Repurposing Drugs for Inflammation and Infectious Diseases

    Kevin Vanstone
    Apr. 14, 2020 01:37PM PST
    Life Science Investing News
    CSE:RVV

    Revive Therapeutics (CSE:RVV) has launched its campaign on the Investing News Network’s life sciences channel.

    Revive Therapeutics (CSE:RVV) has launched its campaign on the Investing News Network’s life sciences channel.

    Revive Therapeutics is a life sciences company working to develop treatments for rare disorders and infectious diseases. The company is focused on developing IP and treatments for infectious diseases while also leveraging compounds like psilocybin to develop new treatments and therapies. Revive Therapeutics is also developing a portfolio of cannabis-based IP with a focus on autoimmune hepatitis and ischemia.

    Revive Therapeutics recently announced it was exploring the use of the drug bucillamine as a potential novel treatment for infectious diseases including influenza and the side effects of the coronavirus disease (COVID-19). The company has applied for a provisional patent with the US Patent and Trademark Office entitled “Use of Bucillamine in the Treatment of Infectious Diseases”.

    Revive Therapeutics’ company highlights include the following:

    • Secured a patent relating to the use of bucillamine in the treatment of gout
    • Applied for a provisional patent with the U.S. Patent and Trademark Office entitled “Use of Bucillamine in the Treatment of Infectious Diseases”
    • Owns a portfolio of four patents regarding cannabinoid delivery systems, including one specific to the treatment of autoimmune hepatitis
    • Received orphan drug status from the US FDA for CBD in the treatment of autoimmune hepatitis
    • Received orphan drug status from the US FDA for bucillamine in the treatment of cystinuria
    • Acquired Psilocin Pharma Corp, a drug development company specializing in the development of psilocybin-based formulations
    • Developing psilocybin-based compounds currently in the preclinical stage leveraging unique delivery mechanisms
    • Filed provisional patent applications for novel psilocybin delivery systems including tablets, oral compositions, hard-shell capsules, gumdrops, oral strips and sublingual and buccal administration.

    Click here to connect with Revive Therapeutics Ltd. (CSE:RVV) and to request an investor presentation.

    revive therapeuticspsilocin pharma corpcse:rvv
    The Conversation (0)

    Go Deeper

    AI Powered
    Senior woman doing exercises alongside closeup of DNA.

    5 US Longevity and Anti-aging Stocks to Watch in 2025

    Row of test tubes and pipette with chemical droplet chemical coming from it.

    Top 5 Small-cap Biotech Stocks of 2025

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×